Study to evaluate relation between side effects of first linechemotherapy in breast cancer patients with Prakruti.

Not yet recruiting

• Conditions: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified. Ayurveda Condition: Breast Cancer,

• Registration Number: CTRI/2021/10/037041
• Lead Sponsor: College of Ayurved and Research Centre Akurdi Pune

Brief Summary

The prevalence rate of breast cancer has increased because of entry of carcinogenic substances through food or inhalation. Secondly lower immunity due to faulty lifestyle is also the cause of breast cancer. India has a breast cancer mortality rate of 12.7% per 100,000 women.4

In this context, Ayurvedic Prakruti Examination may prove to be useful, if the doctor knows which type Prakruti is more prone for side effects of Chemotherapy, then preventive measures can be taken as per Prakruti of a patient.

Thus present research will be a boon both for patient and the doctor.

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2021-09-30
• Study Start: 2021-11-10

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: Female
• Target Recruitment: 76

Inclusion Criteria

Breast cancer patients receiving Chemotherapy.

Exclusion Criteria

Breast cancer patients receiving Chemotherapy but in very critical condition.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Conclusion will be strictly based on statistical analysis	Every 6 months

Secondary Outcome Measures

Name	Time	Method
Which prakruti has more side effects of first line of chemotherapy in breast cancer.	Every 6 months

Trial Locations

Locations (1)

Ayurved Rugnalaya and Sterling Multispeciality Hospital; 🇮🇳 Pune, MAHARASHTRA, India

Ayurved Rugnalaya and Sterling Multispeciality Hospital

🇮🇳Pune, MAHARASHTRA, India

Sagar Bangar

Principal investigator

9022721989

sagar.bangar281993@gmail.com